The interleukin-17 G-197A polymorphism is associated with cyclosporine metabolism and transplant rejection in liver transplant recipients

This study aimed to investigate the effect of and mechanism involved in the SNP on cyclosporine metabolism and outcomes of liver transplantation (LT). The genotype, IL-17 expression, postoperative outcome and cyclosporine concentration were reviewed in 106 LT recipients. The functional relevance of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacogenomics 2019-04, Vol.20 (6), p.447-456
Hauptverfasser: Sun, Bo, Gao, Junwei, Shi, Weifeng, Guo, Yankun, Fan, Junwei, Zhang, Jigang, Li, Xiaoyu, Liu, Gaolin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 456
container_issue 6
container_start_page 447
container_title Pharmacogenomics
container_volume 20
creator Sun, Bo
Gao, Junwei
Shi, Weifeng
Guo, Yankun
Fan, Junwei
Zhang, Jigang
Li, Xiaoyu
Liu, Gaolin
description This study aimed to investigate the effect of and mechanism involved in the SNP on cyclosporine metabolism and outcomes of liver transplantation (LT). The genotype, IL-17 expression, postoperative outcome and cyclosporine concentration were reviewed in 106 LT recipients. The functional relevance of rs2275913 was evaluated by luciferase assay. Furthermore, L02 cells were treated with IL-17 recombinant protein or/and pregnane X receptor (PXR) knockdown lentiviruses, then the expression of PXR, CYP3A4, CYP3A5 and IL-17R were detected by PCR and western blotting. The significant distribution difference at locus G-197A was confirmed between patients with and without rejection (p = 0.035). Patients with acute rejection showed higher IL-17 level than those without rejection. Cyclosporine concentration was associated with the different genotype (p < 0.05). Luciferase assay revealed that 197G genotype had higher luciferase activity than that in 197A genotype (p = 0.009). Furthermore, IL-17 recombinant protein remarkably promoted the expressions of PXR, CYP3A4 and CYP3A5 (p < 0.01), but not IL-17R. PXR knockdown significantly inhibited the mRNA levels of CYP3A4 and CYP3A5 but not IL-17R (p < 0.01), while IL-17 recombinant protein had no influence on the expressions of CYP3A4 and CYP3A5 when PXR was downregulated. This study revealed the possible association of IL-17 G-197A with cyclosporine metabolism and transplant rejection after LT, which might be partly related to the upregulations of CYP3A4/5 dependent on PXR.
doi_str_mv 10.2217/pgs-2018-0198
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2185874186</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2185874186</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-d112869cdea564512324c4a6d24108880b434fa765dd274d21e274bcff3063d73</originalsourceid><addsrcrecordid>eNp1kUFvFCEUx4nR2Np69GpIvHhBgWGAOTZNrU2a9NKeCQtvXNYZGIGx2Y_gty6brSaaeHoQfvx5vB9C7xj9xDlTn5dvhXDKNKFs0C_QKVNCEE0Ff9nWQnLCBZMn6E0pO0o5k4K-RicdVcOgeH-Kft1vAYdYIU-wfg-RMIWvCRvUBV7StJ9TXrahzDgUbEtJLtgKHj-GusVu76ZUlpRDBDxDtZs0HVAbPa7ZxrJMNlacYQeuhhTbM3gKPyH_ferCEiDWco5ejXYq8Pa5nqGHL1f3l1_J7d31zeXFLXGdYpV4xriWg_Ngeyl6xjsunLDSt39SrTXdiE6MVsnee66E5wxa2bhx7KjsvOrO0Mdj7pLTjxVKNXMoDqbWDqS1GM50r5VgWjb0wz_oLq05tu4M50qqQUrKG0WOlMuplAyjWXKYbd4bRs3BkWmOzMGROThq_Pvn1HUzg_9D_5bSgOEIjGtdMxTX5uPAHHftRnBt4v8JfwK-w6Gu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2276796602</pqid></control><display><type>article</type><title>The interleukin-17 G-197A polymorphism is associated with cyclosporine metabolism and transplant rejection in liver transplant recipients</title><source>MEDLINE</source><source>PubMed Central</source><creator>Sun, Bo ; Gao, Junwei ; Shi, Weifeng ; Guo, Yankun ; Fan, Junwei ; Zhang, Jigang ; Li, Xiaoyu ; Liu, Gaolin</creator><creatorcontrib>Sun, Bo ; Gao, Junwei ; Shi, Weifeng ; Guo, Yankun ; Fan, Junwei ; Zhang, Jigang ; Li, Xiaoyu ; Liu, Gaolin</creatorcontrib><description>This study aimed to investigate the effect of and mechanism involved in the SNP on cyclosporine metabolism and outcomes of liver transplantation (LT). The genotype, IL-17 expression, postoperative outcome and cyclosporine concentration were reviewed in 106 LT recipients. The functional relevance of rs2275913 was evaluated by luciferase assay. Furthermore, L02 cells were treated with IL-17 recombinant protein or/and pregnane X receptor (PXR) knockdown lentiviruses, then the expression of PXR, CYP3A4, CYP3A5 and IL-17R were detected by PCR and western blotting. The significant distribution difference at locus G-197A was confirmed between patients with and without rejection (p = 0.035). Patients with acute rejection showed higher IL-17 level than those without rejection. Cyclosporine concentration was associated with the different genotype (p &lt; 0.05). Luciferase assay revealed that 197G genotype had higher luciferase activity than that in 197A genotype (p = 0.009). Furthermore, IL-17 recombinant protein remarkably promoted the expressions of PXR, CYP3A4 and CYP3A5 (p &lt; 0.01), but not IL-17R. PXR knockdown significantly inhibited the mRNA levels of CYP3A4 and CYP3A5 but not IL-17R (p &lt; 0.01), while IL-17 recombinant protein had no influence on the expressions of CYP3A4 and CYP3A5 when PXR was downregulated. This study revealed the possible association of IL-17 G-197A with cyclosporine metabolism and transplant rejection after LT, which might be partly related to the upregulations of CYP3A4/5 dependent on PXR.</description><identifier>ISSN: 1462-2416</identifier><identifier>EISSN: 1744-8042</identifier><identifier>DOI: 10.2217/pgs-2018-0198</identifier><identifier>PMID: 30799725</identifier><language>eng</language><publisher>England: Future Medicine Ltd</publisher><subject>Adolescent ; Adult ; Aged ; cyclosporine ; Cyclosporine - metabolism ; Cyclosporins ; Cytochrome ; Cytochrome P-450 CYP3A - genetics ; Cytokines ; Deoxyribonucleic acid ; Disease ; DNA ; Down-Regulation - genetics ; Drug dosages ; Female ; Gene expression ; Gene polymorphism ; Genotype ; Graft rejection ; Graft Rejection - genetics ; Graft Rejection - metabolism ; Humans ; IL-17 ; Immunology ; Interleukin 17 ; Interleukin-17 - genetics ; Liver ; Liver transplantation ; Liver Transplantation - methods ; Liver transplants ; Male ; Metabolism ; Middle Aged ; mRNA ; Plasmids ; Polymorphism ; Polymorphism, Single Nucleotide - genetics ; Pregnane X Receptor - genetics ; Proteins ; Recombinant Proteins - genetics ; RNA, Messenger - genetics ; Single-nucleotide polymorphism ; Studies ; Transplant Recipients ; Transplants &amp; implants ; Tuberculosis ; Up-Regulation - genetics ; Western blotting ; Young Adult</subject><ispartof>Pharmacogenomics, 2019-04, Vol.20 (6), p.447-456</ispartof><rights>2019 Future Medicine Ltd</rights><rights>Copyright Future Medicine Ltd Apr 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-d112869cdea564512324c4a6d24108880b434fa765dd274d21e274bcff3063d73</citedby><cites>FETCH-LOGICAL-c371t-d112869cdea564512324c4a6d24108880b434fa765dd274d21e274bcff3063d73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30799725$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sun, Bo</creatorcontrib><creatorcontrib>Gao, Junwei</creatorcontrib><creatorcontrib>Shi, Weifeng</creatorcontrib><creatorcontrib>Guo, Yankun</creatorcontrib><creatorcontrib>Fan, Junwei</creatorcontrib><creatorcontrib>Zhang, Jigang</creatorcontrib><creatorcontrib>Li, Xiaoyu</creatorcontrib><creatorcontrib>Liu, Gaolin</creatorcontrib><title>The interleukin-17 G-197A polymorphism is associated with cyclosporine metabolism and transplant rejection in liver transplant recipients</title><title>Pharmacogenomics</title><addtitle>Pharmacogenomics</addtitle><description>This study aimed to investigate the effect of and mechanism involved in the SNP on cyclosporine metabolism and outcomes of liver transplantation (LT). The genotype, IL-17 expression, postoperative outcome and cyclosporine concentration were reviewed in 106 LT recipients. The functional relevance of rs2275913 was evaluated by luciferase assay. Furthermore, L02 cells were treated with IL-17 recombinant protein or/and pregnane X receptor (PXR) knockdown lentiviruses, then the expression of PXR, CYP3A4, CYP3A5 and IL-17R were detected by PCR and western blotting. The significant distribution difference at locus G-197A was confirmed between patients with and without rejection (p = 0.035). Patients with acute rejection showed higher IL-17 level than those without rejection. Cyclosporine concentration was associated with the different genotype (p &lt; 0.05). Luciferase assay revealed that 197G genotype had higher luciferase activity than that in 197A genotype (p = 0.009). Furthermore, IL-17 recombinant protein remarkably promoted the expressions of PXR, CYP3A4 and CYP3A5 (p &lt; 0.01), but not IL-17R. PXR knockdown significantly inhibited the mRNA levels of CYP3A4 and CYP3A5 but not IL-17R (p &lt; 0.01), while IL-17 recombinant protein had no influence on the expressions of CYP3A4 and CYP3A5 when PXR was downregulated. This study revealed the possible association of IL-17 G-197A with cyclosporine metabolism and transplant rejection after LT, which might be partly related to the upregulations of CYP3A4/5 dependent on PXR.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>cyclosporine</subject><subject>Cyclosporine - metabolism</subject><subject>Cyclosporins</subject><subject>Cytochrome</subject><subject>Cytochrome P-450 CYP3A - genetics</subject><subject>Cytokines</subject><subject>Deoxyribonucleic acid</subject><subject>Disease</subject><subject>DNA</subject><subject>Down-Regulation - genetics</subject><subject>Drug dosages</subject><subject>Female</subject><subject>Gene expression</subject><subject>Gene polymorphism</subject><subject>Genotype</subject><subject>Graft rejection</subject><subject>Graft Rejection - genetics</subject><subject>Graft Rejection - metabolism</subject><subject>Humans</subject><subject>IL-17</subject><subject>Immunology</subject><subject>Interleukin 17</subject><subject>Interleukin-17 - genetics</subject><subject>Liver</subject><subject>Liver transplantation</subject><subject>Liver Transplantation - methods</subject><subject>Liver transplants</subject><subject>Male</subject><subject>Metabolism</subject><subject>Middle Aged</subject><subject>mRNA</subject><subject>Plasmids</subject><subject>Polymorphism</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>Pregnane X Receptor - genetics</subject><subject>Proteins</subject><subject>Recombinant Proteins - genetics</subject><subject>RNA, Messenger - genetics</subject><subject>Single-nucleotide polymorphism</subject><subject>Studies</subject><subject>Transplant Recipients</subject><subject>Transplants &amp; implants</subject><subject>Tuberculosis</subject><subject>Up-Regulation - genetics</subject><subject>Western blotting</subject><subject>Young Adult</subject><issn>1462-2416</issn><issn>1744-8042</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kUFvFCEUx4nR2Np69GpIvHhBgWGAOTZNrU2a9NKeCQtvXNYZGIGx2Y_gty6brSaaeHoQfvx5vB9C7xj9xDlTn5dvhXDKNKFs0C_QKVNCEE0Ff9nWQnLCBZMn6E0pO0o5k4K-RicdVcOgeH-Kft1vAYdYIU-wfg-RMIWvCRvUBV7StJ9TXrahzDgUbEtJLtgKHj-GusVu76ZUlpRDBDxDtZs0HVAbPa7ZxrJMNlacYQeuhhTbM3gKPyH_ferCEiDWco5ejXYq8Pa5nqGHL1f3l1_J7d31zeXFLXGdYpV4xriWg_Ngeyl6xjsunLDSt39SrTXdiE6MVsnee66E5wxa2bhx7KjsvOrO0Mdj7pLTjxVKNXMoDqbWDqS1GM50r5VgWjb0wz_oLq05tu4M50qqQUrKG0WOlMuplAyjWXKYbd4bRs3BkWmOzMGROThq_Pvn1HUzg_9D_5bSgOEIjGtdMxTX5uPAHHftRnBt4v8JfwK-w6Gu</recordid><startdate>20190401</startdate><enddate>20190401</enddate><creator>Sun, Bo</creator><creator>Gao, Junwei</creator><creator>Shi, Weifeng</creator><creator>Guo, Yankun</creator><creator>Fan, Junwei</creator><creator>Zhang, Jigang</creator><creator>Li, Xiaoyu</creator><creator>Liu, Gaolin</creator><general>Future Medicine Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>EHMNL</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20190401</creationdate><title>The interleukin-17 G-197A polymorphism is associated with cyclosporine metabolism and transplant rejection in liver transplant recipients</title><author>Sun, Bo ; Gao, Junwei ; Shi, Weifeng ; Guo, Yankun ; Fan, Junwei ; Zhang, Jigang ; Li, Xiaoyu ; Liu, Gaolin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-d112869cdea564512324c4a6d24108880b434fa765dd274d21e274bcff3063d73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>cyclosporine</topic><topic>Cyclosporine - metabolism</topic><topic>Cyclosporins</topic><topic>Cytochrome</topic><topic>Cytochrome P-450 CYP3A - genetics</topic><topic>Cytokines</topic><topic>Deoxyribonucleic acid</topic><topic>Disease</topic><topic>DNA</topic><topic>Down-Regulation - genetics</topic><topic>Drug dosages</topic><topic>Female</topic><topic>Gene expression</topic><topic>Gene polymorphism</topic><topic>Genotype</topic><topic>Graft rejection</topic><topic>Graft Rejection - genetics</topic><topic>Graft Rejection - metabolism</topic><topic>Humans</topic><topic>IL-17</topic><topic>Immunology</topic><topic>Interleukin 17</topic><topic>Interleukin-17 - genetics</topic><topic>Liver</topic><topic>Liver transplantation</topic><topic>Liver Transplantation - methods</topic><topic>Liver transplants</topic><topic>Male</topic><topic>Metabolism</topic><topic>Middle Aged</topic><topic>mRNA</topic><topic>Plasmids</topic><topic>Polymorphism</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>Pregnane X Receptor - genetics</topic><topic>Proteins</topic><topic>Recombinant Proteins - genetics</topic><topic>RNA, Messenger - genetics</topic><topic>Single-nucleotide polymorphism</topic><topic>Studies</topic><topic>Transplant Recipients</topic><topic>Transplants &amp; implants</topic><topic>Tuberculosis</topic><topic>Up-Regulation - genetics</topic><topic>Western blotting</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sun, Bo</creatorcontrib><creatorcontrib>Gao, Junwei</creatorcontrib><creatorcontrib>Shi, Weifeng</creatorcontrib><creatorcontrib>Guo, Yankun</creatorcontrib><creatorcontrib>Fan, Junwei</creatorcontrib><creatorcontrib>Zhang, Jigang</creatorcontrib><creatorcontrib>Li, Xiaoyu</creatorcontrib><creatorcontrib>Liu, Gaolin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>UK &amp; Ireland Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacogenomics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sun, Bo</au><au>Gao, Junwei</au><au>Shi, Weifeng</au><au>Guo, Yankun</au><au>Fan, Junwei</au><au>Zhang, Jigang</au><au>Li, Xiaoyu</au><au>Liu, Gaolin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The interleukin-17 G-197A polymorphism is associated with cyclosporine metabolism and transplant rejection in liver transplant recipients</atitle><jtitle>Pharmacogenomics</jtitle><addtitle>Pharmacogenomics</addtitle><date>2019-04-01</date><risdate>2019</risdate><volume>20</volume><issue>6</issue><spage>447</spage><epage>456</epage><pages>447-456</pages><issn>1462-2416</issn><eissn>1744-8042</eissn><abstract>This study aimed to investigate the effect of and mechanism involved in the SNP on cyclosporine metabolism and outcomes of liver transplantation (LT). The genotype, IL-17 expression, postoperative outcome and cyclosporine concentration were reviewed in 106 LT recipients. The functional relevance of rs2275913 was evaluated by luciferase assay. Furthermore, L02 cells were treated with IL-17 recombinant protein or/and pregnane X receptor (PXR) knockdown lentiviruses, then the expression of PXR, CYP3A4, CYP3A5 and IL-17R were detected by PCR and western blotting. The significant distribution difference at locus G-197A was confirmed between patients with and without rejection (p = 0.035). Patients with acute rejection showed higher IL-17 level than those without rejection. Cyclosporine concentration was associated with the different genotype (p &lt; 0.05). Luciferase assay revealed that 197G genotype had higher luciferase activity than that in 197A genotype (p = 0.009). Furthermore, IL-17 recombinant protein remarkably promoted the expressions of PXR, CYP3A4 and CYP3A5 (p &lt; 0.01), but not IL-17R. PXR knockdown significantly inhibited the mRNA levels of CYP3A4 and CYP3A5 but not IL-17R (p &lt; 0.01), while IL-17 recombinant protein had no influence on the expressions of CYP3A4 and CYP3A5 when PXR was downregulated. This study revealed the possible association of IL-17 G-197A with cyclosporine metabolism and transplant rejection after LT, which might be partly related to the upregulations of CYP3A4/5 dependent on PXR.</abstract><cop>England</cop><pub>Future Medicine Ltd</pub><pmid>30799725</pmid><doi>10.2217/pgs-2018-0198</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1462-2416
ispartof Pharmacogenomics, 2019-04, Vol.20 (6), p.447-456
issn 1462-2416
1744-8042
language eng
recordid cdi_proquest_miscellaneous_2185874186
source MEDLINE; PubMed Central
subjects Adolescent
Adult
Aged
cyclosporine
Cyclosporine - metabolism
Cyclosporins
Cytochrome
Cytochrome P-450 CYP3A - genetics
Cytokines
Deoxyribonucleic acid
Disease
DNA
Down-Regulation - genetics
Drug dosages
Female
Gene expression
Gene polymorphism
Genotype
Graft rejection
Graft Rejection - genetics
Graft Rejection - metabolism
Humans
IL-17
Immunology
Interleukin 17
Interleukin-17 - genetics
Liver
Liver transplantation
Liver Transplantation - methods
Liver transplants
Male
Metabolism
Middle Aged
mRNA
Plasmids
Polymorphism
Polymorphism, Single Nucleotide - genetics
Pregnane X Receptor - genetics
Proteins
Recombinant Proteins - genetics
RNA, Messenger - genetics
Single-nucleotide polymorphism
Studies
Transplant Recipients
Transplants & implants
Tuberculosis
Up-Regulation - genetics
Western blotting
Young Adult
title The interleukin-17 G-197A polymorphism is associated with cyclosporine metabolism and transplant rejection in liver transplant recipients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T22%3A19%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20interleukin-17%20G-197A%20polymorphism%20is%20associated%20with%20cyclosporine%20metabolism%20and%20transplant%20rejection%20in%20liver%20transplant%20recipients&rft.jtitle=Pharmacogenomics&rft.au=Sun,%20Bo&rft.date=2019-04-01&rft.volume=20&rft.issue=6&rft.spage=447&rft.epage=456&rft.pages=447-456&rft.issn=1462-2416&rft.eissn=1744-8042&rft_id=info:doi/10.2217/pgs-2018-0198&rft_dat=%3Cproquest_cross%3E2185874186%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2276796602&rft_id=info:pmid/30799725&rfr_iscdi=true